These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 18812379)

  • 21. Biotechs hedge against big pharma givebacks.
    Dorey E
    Nat Biotechnol; 1999 May; 17(5):416-7. PubMed ID: 10331784
    [No Abstract]   [Full Text] [Related]  

  • 22. Industry funding in medical education.
    Davies P
    Lancet; 2002 Jun; 359(9321):1949-50. PubMed ID: 12057586
    [No Abstract]   [Full Text] [Related]  

  • 23. [Commercialization of the medical research is a reality. What is the limit?].
    Naeser K
    Ugeskr Laeger; 2005 Oct; 167(43):4103; author reply 4103-5. PubMed ID: 16251105
    [No Abstract]   [Full Text] [Related]  

  • 24. [Keep medical education independent! It should not be a scene of drug industry marketing].
    Eliasson G; Håkansson J
    Lakartidningen; 2001 Sep; 98(39):4168-9. PubMed ID: 11680148
    [No Abstract]   [Full Text] [Related]  

  • 25. US Senate committee investigates conflicts of interest in industry funded medical education.
    Tanne JH
    BMJ; 2009 Aug; 339():b3139. PubMed ID: 19654162
    [No Abstract]   [Full Text] [Related]  

  • 26. Education or promotion?
    Noble RC
    N Engl J Med; 1992 Jul; 327(5):363-4. PubMed ID: 1620188
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharma goes to the laundry: Public relations and the business of medical education.
    Elliott C
    Hastings Cent Rep; 2004; 34(5):18-23. PubMed ID: 15553394
    [No Abstract]   [Full Text] [Related]  

  • 28. Medical students protest perks from drug companies.
    Opar A
    Nat Med; 2006 Oct; 12(10):1104. PubMed ID: 17024192
    [No Abstract]   [Full Text] [Related]  

  • 29. A prescription for better prescriptions.
    Woosley RL
    Issues Sci Technol; 1994; 10(3):59-66. PubMed ID: 10133487
    [No Abstract]   [Full Text] [Related]  

  • 30. US senator seeks information about medical faculty links to drug industry.
    Tanne JH
    BMJ; 2009 Jul; 339():b2725. PubMed ID: 19581320
    [No Abstract]   [Full Text] [Related]  

  • 31. US medical schools should say no to pharma support.
    Tanne JH
    BMJ; 2008 May; 336(7652):1035. PubMed ID: 18467393
    [No Abstract]   [Full Text] [Related]  

  • 32. Doctors' education: the invisible influence of drug company sponsorship.
    Moynihan R
    BMJ; 2008 Feb; 336(7641):416-7. PubMed ID: 18292165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Industry sponsorship in research and publishing: who is really to blame for perceived bias?
    Amsden GW
    Ann Pharmacother; 2004 Apr; 38(4):714-6. PubMed ID: 14982974
    [No Abstract]   [Full Text] [Related]  

  • 34. Data availability for industry sponsored trials: what should medical journals require?
    Steinbrook R; Kassirer JP
    BMJ; 2010 Oct; 341():c5391. PubMed ID: 20940213
    [No Abstract]   [Full Text] [Related]  

  • 35. [Medical research and the pharmaceutical industry. Uneasy bedfellows or a prenuptial agreement?].
    Vooren PH
    Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1910. PubMed ID: 11605318
    [No Abstract]   [Full Text] [Related]  

  • 36. A change of course for tertiary education.
    Gould B
    N Z Med J; 2000 Jun; 113(1112):239-40. PubMed ID: 10914505
    [No Abstract]   [Full Text] [Related]  

  • 37. Sponsorship of educational programmes in Nigerian medical and pharmacy schools by pharmaceutical companies: possible risk implication for public health.
    Okoro EO; Davies AE
    Ethics Med; 2001; 17(1):52-60. PubMed ID: 15176368
    [No Abstract]   [Full Text] [Related]  

  • 38. Medical schools fight their corner.
    Gavaghan H
    Nature; 1995 Feb; 373(6516):649. PubMed ID: 7854427
    [No Abstract]   [Full Text] [Related]  

  • 39. How should we support pharmaceutical innovation?
    Grootendorst P
    Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):313-20. PubMed ID: 19670991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The state of innovation in drug development.
    Kola I
    Clin Pharmacol Ther; 2008 Feb; 83(2):227-30. PubMed ID: 18202690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.